# US 6,726,674 B2 · Methods for minimally invasive, localized delivery of sclerotherapeutic agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,674 B2
- Document ID: US6726674B2
- Status: Granted
- Kind: B2
- Application number: 09/944,143
- Filed: 2001-09-04
- Published: 2003-03-06
- Granted: 2004-04-27
- Earliest claimed: 2001-09-04
- Assignees: Jomed GmbH
- Inventors: Anders J. Leu
- Web page: https://patentgrep.com/patent/US6726674B2

## CPC

- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61M 25/1002: {characterised by balloon shape (A61M25/1006, A61M25/1009 take precedence)}
- A61M 2025/105: {having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes}
- A61M 2025/1072: {having balloons with two or more compartments}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Apparatus and methods are provided for localized, minimally invasive administration of sclerotherapy in the treatment of varicose veins. A treatment site within a vein is isolated from blood flow through the vain. Sclerotherapeutic agents are delivered to the isolated vessel segment. A substantial portion of the agents are then removed from the vein, and isolation is removed from the treatment site. Inflammation, clotting, scarring, and closure of the varicose vein ensues at the treatment site. In a preferred embodiment, this technique is accomplished with a catheter having an inflatable member. The inflatable member is expandable to a deployed configuration in which its central region is of reduced cross-section as compared to its proximal and distal regions. The central region comprises one or more perforations extending through the inflatable member so that sclerotherapeutic agents may be delivered through the perforations.

## Claims

### Claim 1

A method of administering sclerotherapy to a varicose vein, the method comprising:
isolating a segment of the varicose vein from blood flow through the vein;
delivering sclerotherapeutic agents to the isolated segment, thereby initiating occlusion of the vein;
removing from the varicose vein a substantial portion of the sclerotherapeutic agents delivered to the isolated segment; and then
removing isolation from the vein segment.

### Claim 2 (depends on 1)

The method of claim 1, wherein the substantial portion comprises a majority of the sclerotherapeutic agents delivered to the isolated segment.

### Claim 3 (depends on 1)

The method of claim 1, wherein the sclerotherapeutic agents are chosen from the group consisting of hypertonic saline, sodium tetradecyl sulfate, and aethoxyskerol.

### Claim 4 (depends on 1)

The method of claim 1, wherein isolating the segment of the varicose vein comprises expanding first and second inflatable members proximal and distal of the vein segment, respectively.

### Claim 5

A method of administering sclerotherapy to a varicose vein, the method comprising:
providing an apparatus comprising a catheter and a inflatable member, the catheter having an inflation lumen coupled to the inflatable member;
the inflatable member reversibly expandable from a collapsed, delivery configuration to an expanded, deployed configuration, the inflatable member having proximal and distal regions, and a central region disposed therebetween;
the central region having a reduced cross-section, as compared to the proximal and distal regions, in the deployed configuration, the central region further comprising at least one perforation extending through the inflatable member;
isolating a segment of the varicose vein from blood flow through the vein by expanding the inflatable member from the delivery configuration to deployed configuration;
delivering sclerotherapeutic agents to the isolated segment through the at least one perforation, thereby initiating occlusion of the vein removing a substantial portion of the sclerotherapeutic agents delivered to the isolated segment; and then
removing isolation from the vein segment.

### Claim 6 (depends on 5)

The method of claim 5, wherein
expanding the inflatable member comprises sealingly engaging an interior surface of the varicose vein proximally and distally of the vein segment with the proximal and distal regions of the inflatable member, respectively.

### Claim 7 (depends on 5)

The method of claim 5, wherein
expanding the inflatable member comprises injecting sclerotherapeutic agents through the inflation lumen of the catheter.

### Claim 8 (depends on 5)

The method of claim 5, wherein
delivering sclerotherapeutic agents to the isolated segment comprises injecting an additional volume of the sclerotherapeutic agents through the inflation lumen after the inflatable member has been expanded to the deployed configuration, thereby causing a portion of the sclerotherapeutic agents to pass through the at least one perforation in the central region of the inflatable member.

### Claim 9 (depends on 5)

The method of claim 5, wherein
removing isolation from the vein segment comprises collapsing the inflatable member back to the delivery configuration.

### Claim 10 (depends on 9)

The method of claim 9, wherein
collapsing the inflatable member back to the delivery configuration comprises removing the sclerotherapeutic agents form the inflatable member through the inflation lumen.

### Claim 11 (depends on 9)

The method of claim 9 further comprising
removing the apparatus from the varicose vein.

### Claim 12 (depends on 5)

The method of claim 5 further comprising,
prior to removing isolation from the vein segment, removing from the varicose vein a substantial portion of the sclerotherapeutic agents delivered to the isolated segment.

### Claim 13 (depends on 12)

The method of claim 12, wherein
removing the substantial portion of the sclerotherapeutic agents comprises removing the agents from the isolated segment through the at least one perforation and through the inflation lumen.

### Claim 14 (depends on 5)

The method of claim 5, wherein the catheter further comprises a guide wire lumen, and wherein isolating the vein segment further comprises:
prior to expanding the inflatable member, advancing a guide wire to the vein segment using well-known percutaneous techniques; and
advancing the catheter over the guide wire to the vein segment via the guide wire lumen.

### Claim 15 (depends on 5)

The method of claim 5, wherein the apparatus further comprises an infusion lumen coupled to the at least one perforation extending through the inflatable member, and wherein delivering sclerotherapeutic agents to the isolated segment comprises injecting sclerotherapeutic agents through the infusion lumen.

### Claim 16 (depends on 15)

A The method of claim 15, wherein
removing the substantial portion of the sclerotherapeutic agents comprises removing the agents from the isolated segment through the at least one perforation and through the infusion lumen.

### Claim 17 (depends on 5)

The method of claim 5, wherein the apparatus further comprises an additional lumen extending axially across the inflation lumen to allow blood to flow therethrough.

### Claim 18 (depends on 17)

The method of claim 17 further comprising
maintaining blood flow through the varicose vein while the vein segment is isolated by flowing the blood through the additional lumen.
